This product uses immunochromatography and double antibody sandwich methods to qualitatively detect novel coronavirus, influenza A, and influenza B virus antigens in human respiratory nasal swabs in vitro. The product has high sensitivity, specificity, and accuracy, and is suitable for daily self-testing and auxiliary diagnosis. The product has CE certification and registration certifications in many countries, and can be used in medical service institutions such as pharmacies and clinics.